Eddit
| Zeile 84: | Zeile 84: | ||
*'''[[Dermatology]]''' | *'''[[Dermatology]]''' | ||
| + | |||
*'''[[Gastroenterology, hepatology]]''' | *'''[[Gastroenterology, hepatology]]''' | ||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
*'''[[Kidney, urology]]== | *'''[[Kidney, urology]]== | ||
| Zeile 113: | Zeile 94: | ||
* | * | ||
*'''[[Pathobiology]]''' | *'''[[Pathobiology]]''' | ||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| Zeile 147: | Zeile 118: | ||
*'''[[Respiration mgmt]]''' | *'''[[Respiration mgmt]]''' | ||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
*'''[[Clinical guidelines and advice]]''' | *'''[[Clinical guidelines and advice]]''' | ||
| Zeile 160: | Zeile 124: | ||
*'''[[Risk and special populations]]''' | *'''[[Risk and special populations]]''' | ||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
*'''[[Case reports]]''' | *'''[[Case reports]]''' | ||
{{tp|p=32241316|t=ä. Case Report on Early Diagnosis of COVID-19 |pdf=|usr=}} | {{tp|p=32241316|t=ä. Case Report on Early Diagnosis of COVID-19 |pdf=|usr=}} | ||
| Zeile 226: | Zeile 171: | ||
* | * | ||
*'''[[Running your hospital]]''' | *'''[[Running your hospital]]''' | ||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
*'''[[Mental aspects of health professionals]]''' | *'''[[Mental aspects of health professionals]]''' | ||
{{tp|p=32342698|t=ä. Mental health care for medical staff and affiliated healthcare workers during the COVID-19 pandemic |pdf=|usr=}} | {{tp|p=32342698|t=ä. Mental health care for medical staff and affiliated healthcare workers during the COVID-19 pandemic |pdf=|usr=}} | ||
| Zeile 348: | Zeile 216: | ||
*'''[[Epidemiology]]''' | *'''[[Epidemiology]]''' | ||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
*'''[[Failure of politics and public health guidance]]''' | *'''[[Failure of politics and public health guidance]]''' | ||
| Zeile 399: | Zeile 235: | ||
*[[coviki state of development]] | *[[coviki state of development]] | ||
*'''[[misc.]]''' | *'''[[misc.]]''' | ||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
*'''[[from the ads]]''' | *'''[[from the ads]]''' | ||
*[http://www.okaybio.com covid19 antibodies, proteins & reagents] | *[http://www.okaybio.com covid19 antibodies, proteins & reagents] | ||
*[http://www.reactionbiology.com 700 kinsse assays] | *[http://www.reactionbiology.com 700 kinsse assays] | ||
Version vom 21. Mai 2020, 17:02 Uhr
32240462 ä. Coronavirus disease 2019 (COVID-19): a clinical update
32318975 ä. Advances in COVID-19: the virus, the pathogenesis, and evidence-based control and therapeutic strategies
32363223 ä. Genomics functional analysis and drug screening of SARS-CoV-2
32120965 2020. Outbreak of Novel Coronavirus (SARS-CoV-2): First Evidences From International Scientific Literature and Pending Questions
32333304 ä. SARS-Cov-2 (human) and COVID-19: Primer 2020
32142596 2020. Machine Learning, COVID?19 (2019?nCoV), and multi?OMICS
32187834 2020. ..COVID19: Cytometry and the New Challenge for Global Health
32270412 ä. Ultrarapid diagnosis, microscope imaging, genome sequencing, and culture isolation of SARS-CoV-2
32265007 2020. Whole genome and phylogenetic analysis of two SARS-CoV-2 strains isolated in Italy in January and February 2020: additional clues on multiple introductions and further circulation in Europe
32210741 2020. Unrevealing sequence and structural features of novel coronavirus using in silico approaches: The main protease as molecular target
32194944 2020. Prediction of the SARS-CoV-2 (2019-nCoV) 3C-like protease (3CL pro) structure: virtual screening reveals velpatasvir, ledipasvir, and other drug repurposing candidates
32300673 2020. Genomic characterization of a novel SARS-CoV-2
32353474 ä. Genotyping coronavirus SARS-CoV-2: Methods and implications
32220422 2020. The hosts angiotensin-converting enzyme polymorphism may explain epidemiological findings in COVID-19 infections
32336612 ä. The pivotal link between ACE2 deficiency and SARS-CoV-2 infection
32210742 2020. Role of changes in SARS-CoV-2 spike protein in the interaction with the human ACE2 receptor: An in silico analysis
32327200 ä. Covid-19 and the angiotensin-converting enzyme (ACE2): Areas for research
32271376 ä. Factors associated with prolonged viral RNA shedding in patients with COVID-19
32348472 ä. A Marker of Systemic Inflammation or Direct Cardiac Injury: Should Cardiac Troponin Levels be Monitored in COVID-19 Patients?
32371463 2020. Clinicopathological characteristics of 8697 patients with COVID-19 in China: a meta-analysis
32354800 2020. Cardiovascular manifestations and treatment considerations in covid-19
32305329 2020. Cardiovascular and Logistic Issues Associated With COVID-19 Pandemic
32373465 ä. Syncope as the presenting symptom of COVID-19 infection
32315757 ä. Current data on the cardiovascular effects of the COVID-19
32140732 ä. SARS-CoV-2: a potential novel etiology of fulminant myocarditis
32333026 ä. Arrhythmias and sudden cardiac death in the COVID-19 pandemic
32322935 ä. SARS-CoV-2 as potential cause of cardiac inflammation and heart failure Is it the virus, hyperinflammation, or MODS?
32367431 ä. Neurological manifestations of patients with COVID-19: potential routes of SARS-CoV-2 neuroinvasion from the periphery to the brain
32373061 2020. Triage of Acute Ischemic Stroke in Confirmed COVID-19: Large Vessel Occlusion Associated With Coronavirus Infection
32362868 2020. Long-Term Neurological Threats of COVID-19: A Call to Update the Thinking About the Outcomes of the Coronavirus Pandemic
32333104 ä. A child confirmed COVID-19 with only symptoms of conjunctivitis and eyelid dermatitis
32328758 ä. The prevalence of ophthalmic manifestations in COVID-19 and the diagnostic value of ocular tissue/fluid
32299479 2020. Acute kidney injury in SARS-CoV-2 infected patients
32197060 2020. Rhabdomyolysis as Potential Late Complication Associated with COVID-19
32215622 ä. Simulation of the clinical and pathological manifestations of Coronavirus Disease 2019 (COVID-19) in golden Syrian hamster model: implications for disease pathogenesis and transmissibility
32378471 2020. Animal models for emerging coronavirus: progress and new insights
31859605 2020. Genetic manipulation of porcine deltacoronavirus reveals insights into NS6 and NS7 functions: a novel strategy for vaccine design
32186278 2020. Influenza-associated pneumonia as reference to assess seriousness of coronavirus disease (COVID-19)
32204949 ä. An update on CT chest findings in coronavirus disease-19 (COVID-19)
32276598 2020. Using echocardiography to guide the treatment of novel coronavirus pneumonia
32307120 ä. Palliative care strategies offer guidance to clinicians and comfort for COVID-19 patient and families
32241316 ä. Case Report on Early Diagnosis of COVID-19
32343659 2020. A Moderate Case of COVID-19 Viral Pneumonia During the SARS-CoV-2 Pandemic
32160149 2020. Severe Acute Respiratory Syndrome Coronavirus 2 from Patient with 2019 Novel Coronavirus Disease, United States
32170559 ä. Combination of western medicine and Chinese traditional patent medicine in treating a family case of COVID-19 in Wuhan
32221725 ä. Brief report of the first cured 2019-nCoV pneumonia patient in West China Hospital
32212512 2020. Retrospective Analysis of 61 Cases of Children Died of Viral Pneumonia
32363222 ä. The clinical and immunological features of pediatric COVID-19 patients in China
32333027 ä. The COVID-19 Registry in Rhineland-Palatinate in the context of international registry activities documenting COVID-19 outcomes
32329589 2020. Rehabilitation management of patients with COVID-19 Lessons learned from the first experiences in China
32316718 2020. Systematic rapid "living" review on rehabilitation needs due to covid-19: update to march 31st 2020
32293817 2020. Rehabilitation and respiratory management in the acute and early post-acute phase "Instant paper from the field" on rehabilitation answers to the Covid-19 emergency
32217657 ä. Urgent need of a management plan for survivors of COVID-19
C7102592 ä. Core Outcome Set for Clinical Trials on Coronavirus Disease 2019 (COS-COVID)
32374074 2020. Potential anti-SARS-CoV-2 drug candidates identified through virtual screening of the ChEMBL database for compounds that target the main coronavirus protease
32265848 2020. Subunit Vaccines Against Emerging Pathogenic Human Coronaviruses
32363145 ä. An algorithm for managing QT prolongation in coronavirus disease 2019 (COVID-19) patients treated with either chloroquine or hydroxychloroquine in conjunction with azithromycin: Possible benefits of intravenous lidocaine
32363144 ä. Inpatient use of mobile continuous telemetry for COVID-19 patients treated with hydroxychloroquine and azithromycin
32247692 ä. Faecal-oral transmission of SARS-COV-2: practical implications
32367287 ä. New evidence of SARS-CoV-2 transmission through the ocular surface
32363144 ä. Inpatient use of mobile continuous telemetry for COVID-19 patients treated with hydroxychloroquine and azithromycin
32251729 ä. The Greek study in the effects of colchicine in COvid-19 complications prevention (GRECCO-19 study): Rationale and study design
32313872 ä. COVID-19 convalescent plasma transfusion
32251365 ä. Considering mutational meltdown as a potential SARS-CoV-2 treatment strategy
32353457 ä. COVID-19 pandemic and personal protective equipment shortage: protective efficacy comparing masks and scientific methods for respirator reuse
32341947 ä. Masks and thermometers: Paramount measures to stop the rapid spread of SARS-CoV-2 in the United States
32221693 ä. Does hand hygiene reduce SARS-CoV-2 transmission?
32346616 2020. Frequent handwashing amidst the COVID?19 outbreak: prevention of hand irritant contact dermatitis and other considerations
32342698 ä. Mental health care for medical staff and affiliated healthcare workers during the COVID-19 pandemic
32346406 2020. COVID-19 pandemic and its impact on mental health of healthcare professionals
32346373 2020. Survey of Insomnia and Related Social Psychological Factors Among Medical Staff Involved in the 2019 Novel Coronavirus Disease Outbreak
32351128 ä. COVID 19 outbreak: impact of the quarantine-induced stress on cardiovascular disease risk burden
32363492 ä. Prevalence and socio-demographic correlates of psychological health problems in Chinese adolescents during the outbreak of COVID-19
32371988 ä. COVID-19 pandemic: the effects of quarantine on cardiovascular risk
32335765 ä. Humanistic Epidemiology: Love in the time of cholera, COVID-19 and other outbreaks
32317197 ä. Health anxiety and behavioural changes of pregnant women during the COVID-19 pandemic
32350453 ä. SARS-CoV-2 self-isolation: recommendations for people with a vision impairment
32279023 2020. Epidemic psychiatry: The opportunities and challenges of COVID-19
32215365 2020. A nationwide survey of psychological distress among Chinese people in the COVID-19 epidemic: implications and policy recommendations
32367286 ä. May home confinement during the COVID-19 outbreak worsen the global burden of myopia?
- Occupational medicine, workplace security and status hygienicus
- Economic aspects of the status hygienicus
32300537 ä. The economic impact of the Coronavirus 2019 (Covid-2019): Implications for the mining industry
32331259 2020. The Food Systems in the Era of the Coronavirus (COVID-19) Pandemic Crisis
32315281 2020. Possible Bat Origin of Severe Acute Respiratory Syndrome Coronavirus 2
32315626 2020. Probable Pangolin Origin of SARS-CoV-2 Associated with the COVID-19 Outbreak
32148173 2020. Is SARS-CoV-2 originated from laboratory? A rebuttal to the claim of formation via laboratory recombination
32102621 2020. No credible evidence supporting claims of the laboratory engineering of SARS-CoV-2
32056509 2020. HIV-1 did not contribute to the 2019-nCoV genome
32373134 2020. Commentary: Origin and evolution of pathogenic coronaviruses
32183934 2020. Post-discharge surveillance and positive virus detection in two medical staff recovered from coronavirus disease 2019 (COVID-19), China, January to February 2020
32363133 ä. The Inadequacy of Regulatory Frameworks in Time of Crisis and in Low-Resource Settings: Personal Protective Equipment and COVID-19
C7152572 ä. Coronavirus Goes Viral: Quantifying the COVID-19 Misinformation Epidemic on Twitter
32241328 ä. Limited Early Warnings and Public Attention to Coronavirus Disease 2019 in China, January?February, 2020: A Longitudinal Cohort of Randomly Sampled Weibo Users
32332201 2020. Infodemic and the spread of fake news in the COVID-19-era
32345850 2020. Collateral damage of the COVID-19 outbreak: expression of concern
